Skip to main content

Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer CO45042 Krascendo 2

Status: Open to Enrollment
Email Us To Enroll

Study Details

View study details on clinicaltrials.gov.

Locations

  • San Francisco
  • Mountain View
  • Palo Alto
  • San Mateo
  • Roseville
  • Sunnyvale

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Patients With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Kevin Kim
Kevin Kim
Principal investigator
View Profile

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?